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Abstract
Objectives To investigate the accuracy of bone mineral den-
sity (BMD) quantification using dual-layer spectral detector
CT (SDCT) at various scan protocols.
Methods Two validated anthropomorphic phantoms contain-
ing inserts of 50–200 mg/cm3 calcium hydroxyapatite (HA)
were scanned using a 64-slice SDCTscanner at various acqui-
sition protocols (120 and 140 kVp, and 50, 100 and 200mAs).
Regions of interest (ROIs) were placed in each insert and
mean attenuation profiles at monochromatic energy levels
(90–200 keV) were constructed. These profiles were fitted to
attenuation profiles of pure HA and water to calculate HA
concentrations. For comparison, one phantom was scanned
using dual energy X-ray absorptiometry (DXA).
Results At both 120 and 140 kVp, excellent correlations (R =
0.97, P < 0.001) were found between true and measured HA
concentrations. Mean error for all measurements at 120 kVp
was -5.6 ± 5.7 mg/cm3 (-3.6 ± 3.2%) and at 140 kVp -2.4 ±
3.7 mg/cm3 (-0.8 ± 2.8%). Mean measurement errors were
smaller than 6% for all acquisition protocols. Strong linear
correlations (R2 ≥ 0.970, P < 0.001) with DXAwere found.
Conclusions SDCT allows for accurate BMD quantification
and potentially opens up the possibility for osteoporosis eval-
uation and opportunistic screening in patients undergoing
SDCT for other clinical indications. However, patient studies
are needed to extend and translate our findings.
Key points
• Dual-layer spectral detector CT allows for accurate bone
mineral density quantification.
• BMD measurements on SDCTare strongly linearly correlat-
ed to DXA.
• SDCT, acquired for several indications, may allow for eval-
uation of osteoporosis.
• This potentially opens up the possibility for opportunistic
osteoporosis screening.
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Introduction
Osteoporosis is a disease associated with low bone mineral
density (BMD), increasing the risk for fractures, and thereby
contributes substantially to morbidity and mortality and
carries social and economic burdens [1]. Bone mineral density
is found to be an independent predictor for future fracture risk
and all-cause mortality [2, 3]. Early detection and treatment of
osteoporosis by using BMD measurements can contribute to
the prevention of osteoporosis-related fractures [3].
BMD derived from dual energy X-ray absorptiometry
(DXA) is the preferred method for the assessment of osteopo-
rosis according to the World Health Organisation [4]. DXA is
widely implemented due to its low costs and low radiation
exposure. However, particularly in elderly subjects, the use
of the projection DXA technique, which measures an areal
BMD (aBMD) in g/cm2, is sensitive for errors. There is the
size dependency of an areal BMD measurement; artefacts
which cause inaccuracies (overlying soft tissue, aortic calcifi-
cations, vertebral fractures and spinal degenerative changes);
and integral bone measurements as DXA measures the whole
vertebra including the neural arch, thereby including the cor-
tical bone [5], whereas the inner trabecular bone is found to be
more metabolically active and thus more influenced by chang-
es in bone mineral density [6]. Quantitative computed tomog-
raphy (QCT) is unaffected by these problems, and in addition
also allows for a differentiation of cortical and trabecular bone
[6]. However, QCT is subject to higher radiation exposure and
typically requires an in-scan calibration phantom, eliminating
the option for routine BMD measurements in CT acquired for
any indication. Recent studies proposed the use of CT num-
bers on regular clinically obtained conventional CT scans for
the use of BMD assessment with varying sensitivity and spec-
ificity of 62–93% and 79–97%, respectively, when compared
to DXA [7–10]. In addition, asynchronous BMD calibration
using a separate phantom calibration scan, and internal BMD
calibration using the paraspinal muscle and subcutaneous fat
as reference materials, have been proposed [10]. However,
bone density measurements on conventional single-energy
CT can be substantially affected by scanner instability, X-ray
tube voltages, intravenous contrast medium injection, pres-
ence of fat within bone marrow, beam hardening artefacts,
patient scatter and metal artefacts [5, 10–14].
With the use of dual energy computed tomography
(DECT) artefacts can be reduced and beam hardening can be
eliminated [15]. More importantly, with DECT materials can
be distinguished by using material decomposition (MD)
algorithms [15]. During the eighties DECT for the assessment
of BMD was explored by several research groups [12, 13,
16–19]. This allowed for BMD measurements with minimal
influence of bone marrow fat [12, 13]. However, mainly due
to increased radiation dose of the DECT and an improved
precision of single-energy CT protocols, DECT was aban-
doned. However, DECT was revived and became commer-
cially available a decade ago [20–23]. Since then BMD has
been evaluated with dual source DECT [20–22] and rapid
kVp switching DECT [23]. For both DECT approaches, a
specific DECT protocol has to be selected before scanning
the patient, eliminating the option for retrospective BMDmea-
surements when DECTwas not selected.
Recently a novel DECT technique has become commer-
cially available that enables retrospective dual energy analyses
on all scan protocols when images are acquired at 120 or 140
kVp. The novel dual-layer spectral detector CT (SDCT) uses a
single tube with a dual-layer detector separating low and high
energy X-ray photons to reconstruct dual energy images. In
addition, a conventional image for clinical use is always re-
constructed from the data by combining the output of both
layers, eliminating the need to select a DECT protocol before-
hand. This could potentially open up the possibilities for ret-
rospective BMD evaluation and opportunistic screening for
osteoporosis on all SDCT scans acquired for regular clinical
indications and thereby potentially eliminating the need for an
additional DXA scan. However, to the best of our knowledge
BMD has not yet been assessed on SDCT and the accuracy is
thus unknown. Therefore, the aim of this study was to evaluate




An anthropomorphic European spine phantom (ESP; QRM
GmbH, Moehrendorf, Germany) on top of a bone density
calibration phantom (BDC; QRM GmbH, Moehrendorf,
Germany) was imaged on a SDCT system (Fig. 1).
Subsequently the ESP was scanned on a DXA system. The
ESP resembles the lumbar region of a small adult person and
is used as standard for quality control in CT and DXA [24].
The phantom consists of water-equivalent resin containing
three vertebral inserts with different BMD quantities. BMD
is defined as the amount of calcium hydroxyapatite (HA) or
Ca5[OH|(PO4)3] per volume unit of bone. The ESP contains
three different inserts with trabecular bone compartments con-
taining nominal design values of 50, 100 and 200 mg/cm3 HA
to mimic a (patho)physiological range of BMD. Measured on
DXA these vertebral inserts represent an areal BMD (aBMD)
of 0.5, 1.0 and 1.5 g/cm2 HA, respectively. The BDC phantom
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contains three cylindrical inserts with a diameter of 18 mm
containing a nominal design value of 0, 100 and 200 mg/cm3
HA. The specific ESP phantom (ESP-143) and BDC phantom
(BDC-03-29) used in this study consisted of 51.2, 102.3 and
201.2 mg/cm3 HA and 0, 104.4 and 206.2 mg/cm3 HA, re-
spectively. For clarity, the nominal design values are used in
the remainder of the text, whereas the latter phantom specific
concentrations were used as true HA concentration for deter-
mining accuracy. The manufactured accuracy of these certi-
fied HAvalues is 1% [24]. In standard single-energy QCT the
BDC phantom allows for calibration of the measured
Hounsfield units (HU) to BMD, which are then applied to
the subject (replaced in this case by the ESP). However, in
our DECT setup the BMD calibration is no longer required;
instead the BDC was used as an additional check to test the
accuracy of BMD quantification on SDCT.
SDCT image acquisition and reconstruction
The phantoms were scanned with a novel 64 detector row
SDCT system (iQon Spectral CT, Philips Healthcare, Best,
The Netherlands). The SDCT uses a single beam and a single
detector with two layers in which the top layer detects low-
energy X-ray photons and the bottom layer high-energy X-ray
photons. This information is used to reconstruct spectral-
based images (SBI), allowing for dual energy options. In ad-
dition, conventional images are automatically reconstructed
by combining the information detected on both layers.
Images were acquired in spiral mode at 120 and at 140 kVp.
Tube current time product was set to 50, 100 and 200 mAs to
simulate various abdominal, chest and spine SDCT imaging
protocols, resulting in a volumetric CT dose index (CTDIvol)
of, respectively, 4.5, 9.0 and 18.1 mGy at 120 kVp and 6.5,
13.0 and 26.0 mGy at 140 kVp. Dose length product (DLP)
was calculated by multiplying the CTDIvol with the scan
length of 12.3 cm. An estimation of the effective dose was
calculated by multiplying the DLP by a conversion coefficient
of 0.0153 mSv/[mGy•cm] for 120 kVp acquisitions and
0.0155 mSv/[mGy•cm] for 140 kVp acquisitions (Table 1)
[25]. CT data were obtained using 64x0.625 mm collimation,
pitch 0.925 and gantry rotation time 0.4 s.
The raw projection data from both detector layers were
reconstructed into SBI with standard filter B using spectral
level 0. Spectral reconstruction is a model-based iterative re-
construction algorithm developed for SDCTwith levels rang-
ing from 0 to 6, whereby a higher level implies more noise
reduction. In addition to spectral level 0, spectral levels 1–6
were reconstructed to analyse the influence of iterative recon-
struction on BMD quantification. Subsequently, images at
monochromatic X-ray photon energies were formed based
on the raw data in the projection space. Slice thickness and
increment were both 3 mm. Reconstructed images were
analysed on a dedicated workstation (IntelliSpace Portal
v6.5.0.02080, Philips Healthcare).
SDCT image analysis and BMD quantification
On the ESP images, a circular region of interest (ROI)
with a fixed area of 450 mm2 was analysed in the
centre of the trabecular bone of the vertebral insert
(Fig. 2A). On the BDC images, a ROI with a fixed area
of 150 mm2 was analysed in the centre of the insert
(Fig. 2A). The water insert of the BDC was not used.
For each scan, ROIs of three different slices per
(vertebral) insert in both the ESP and BDC scans were
analysed. For each ROI, mean HU were plotted against
monochromatic energy levels between 90 and 200 keV
(Fig. 2B). This range was chosen to suffer the least
from potential metal artefacts [26, 27]. In steps of
10 keV, profiles of mean attenuation were constructed.
So far the manufacturer software does not derive BMD
from the monochromatic images. Therefore BMD values
were calculated using in-house developed software by
Fig. 1 Phantom setup. An anthropomorphic European spine phantom on
top of a bone density calibration phantom
Table 1 Scan protocols
kVp mAs CTDIvol (mGy) DLP (mGy · cm) ED (mSv)
140 200 26.0 319.8 5.0
120 200 18.1 222.6 3.4
140 100 13.0 159.9 2.5
120 100 9.0 110.7 1.7
140 50 6.5 80.0 1.2
120 50 4.5 55.4 0.8
CTDIvol volumetric CT dose index, cm centimetre, DLP dose length
product, ED effective radiation dose, estimated as DLP · k (k 0.0153 for
120 kVp and k 0.0155 for 140 kVp), kVp kilovoltage peak, mAs milli-
ampere second, mGy milligray, mSv millisievert
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fitting the constructed attenuation profiles to known at-
tenuation profiles of HA and water (Fig. 2C).The
known attenuation profiles were obtained from the
National Institute of Standards and Technology (NIST)
database [28]. For this method no calibration phantom
was needed.
For the purpose of the analysis, results from the three slices
were averaged per corresponding insert. In addition, the re-
sults of the 100 and 200 mg/cm3 HA inserts of the ESP and
BDC were also combined. Thus three, six and six individual
measurements per scan contributed to the average results of
the 50, 100, and 200 mg/cm3 inserts, respectively.
DXA image acquisition and BMD quantification
For comparison, the ESP was also scanned on a DXA
system (Hologic Discovery A, Hologic Inc., Bedford,
MA, USA) using standard settings routinely used in
clinical practice. Images of the vertebral inserts were
acquired in posterior-anterior position. A rectangular
ROI was manually drawn over each vertebral insert to
segment the bone region and quantify the aBMD in
g/cm2. For the comparison between SDCT and DXA
only the ESP measurements were used.
Statistical analysis
The primary study outcome measure was accuracy
expressed as measurement errors of the investigated
method on SDCT. Measurement errors were defined as
the difference between the measured HA and the true
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All measurements performed at 120 and 140 kVp were
analysed separately. Spearman’s rho correlation coefficient be-
tween measured and true HA concentration was determined for
all measurements. The Shapiro-Wilk test was used to evaluate
normality of the data. Statistical differences of all measurement
errors between 120 and 140 kVpwere analysed using the paired
t-test, comparing the mean of the two samples of related data.
Statistical differences of measurement errors between different
scan protocols and different iterative reconstruction levels were
analysed using the repeated measures analysis of variance
(ANOVA) and post hoc pairwise comparison with Bonferroni
correction. Mauchly’s test was used to test the assumption of
sphericity. The Greenhouse-Geisser correction was used when
this assumptionwas violated. The correlation betweenmeasured
HA concentrations on SDCT and aBMD measured on DXA
was evaluated using linear regression analyses. Values are listed
as mean with standard deviation (SD), unless stated otherwise.
A P-value <0.05 was used to indicate statistical significance.
IBM SPSS version 21.0 (IBM corp., Armonk, NY, USA) was
used for statistical analyses.
Fig. 2 Image analyses and bone mineral density quantification. (A)
Axial image with a ROI drawn in the ESP (blue) and BDC (pink and
green). (B) Spectral plot for the corresponding ROIs: mean HU versus
monochromatic energy level (keV). (C) Attenuation profiles were
constructed between 90 and 200 keV in steps of 10 keV. Using in-
house developed software, HA concentrations were calculated by fitting
the constructed profiles to known attenuation profiles of pure HA and
pure water. For this image this concerns ROI S3, an insert with a phantom
design value of 200 mg/cm3 HA concentration. Av average, BDC bone
density calibration phantom, ESP European spine phantom, HA calcium
hydroxyapatite, HU Hounsfield units, keV kilo electron voltage, ROI
region of interest, SD standard deviation
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Results
At both 120 and 140 kVp excellent correlations (R = 0.97 and
0.97, respectively, P < 0.001) were found between true and
measured HA concentrations. The mean error for all measure-
ments (N = 90) was -4.0 ± 5.0 mg/cm3 (-2.2 ± 3.3%). The
mean error for all measurements at 120 kVp (N = 45) was -
5.6 ± 5.7 mg/cm3 (-3.6 ± 3.2%) and was significantly (P <
0.001) more deviated from the true concentration than the
mean measurement error at 140 kVp (N = 45) of -2.4 ±
3.7 mg/cm3 (-0.8 ± 2.8%). At the 50 mg/cm3 HA insert, over-
all mean measurement errors at 120 kVp were more accurate
than overall mean measurement errors at 140 kVp, while at
100 and 200 mg/cm3 HA inserts overall mean measurement
Table 2 Mean measurement
errors. Subdivided by nominal
design concentrations, mAs and
kVp
True BMD concentration (mg/cm3) mAs 120 kVp 140 kVp
Measurement error Measurement error
mg/cm3 % mg/cm3 %
50* All -0.9 ± 2.1 -1.8 ± 4.0 1.6 ± 1.1 3.1 ± 2.1
200 0.3 ± 1.5 0.5 ± 2.9 0.9 ± 1.0 1.8 ± 1.9
100 -0.2 ± 0.6 -0.5 ± 1.1 1.5 ± 0.6 2.9 ± 1.1
50 -2.8 ± 2.6 -5.5 ± 5.1 2.3 ± 1.5 4.5 ± 2.9
100* All -3.0 ± 2.7 -2.9 ± 2.6 -0.7 ± 1.8 -0.7 ± 1.7
200 -2.7 ± 1.8 -2.6 ± 1.8 -0.5 ± 2.0 -0.5 ± 1.9
100 -2.1 ± 3.8 -2.0 ± 3.7 -0.5 ± 2.0 -0.5 ± 1.9
50 -4.1 ± 2.2 -4.0 ± 2.1 -1.1 ± 1.6 -1.1 ± 1.5
200* All -10.6 ± 5.3 -5.3 ± 2.7 -6.0 ± 2.7 -2.9 ± 1.3
200 -9.6 ± 4.6 -4.7 ± 2.3 -6.4 ± 1.6 -3.2 ± 0.8
100 -10.5 ± 5.2 -5.2 ± 2.6 -6.7 ± 3.1 -3.3 ± 1.5
50 -11.8 ± 6.7 -5.8 ± 3.4 -4.8 ± 3.1 -2.4 ± 1.6
Data are given as mean ± standard deviation. For 50mg/cm3 nine measurements and for 100 and 200 mg/cm3 18
measurement were performed at both 120 and 140 kVp (three and six,respectively, per mAs value)
BMD bone mineral density, kVp kilovoltage peak, mAs milliampere second
* Phantom specific concentrations (ESP-143; 51.2, 102.3 and 201.2 mg/cm3 HA and BDC-03-29; 104.4 and
206.2 mg/cm3 HA) were used to determine measurement error
100 20050
3)*
Fig. 3 Accuracy of dual-layer
detector spectral CT for bone
mineral density quantification.
Mean relative errors (%) per
protocol per nominal design HA
concentration are shown.
Symbols indicate mean
measurement error (%) and error
bars standard deviation. * =
Phantom specific concentrations
(ESP-143; 51.2, 102.3 and
201.2 mg/cm3 HA and BDC-03-
29; 104.4 and 206.2 mg/cm3 HA)
were used to determine deviation.
CTDIvol volumetric CT dose
index, ESP European spine
phantom, HA calcium
hydroxyapatite, kVp kilovoltage
peak, mAs milliampere second,
mGy milligray, SD standard
deviation
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errors at 140 kVp were more accurate (Table 2). When
analysing all scan protocols separately, HA quantifications
were overall accurate with relative mean measurement errors
smaller than 6% for all scan protocols (Fig. 3). Highest relative
measurement errors were obtained for the protocol with the
lowest dose, 120 kVp 50mAs. At the 50, 100 and 200mg/cm3
HA inserts relative measurement errors for this lowest dose
protocol were -5.5 ± 5.1%, -4.0 ± 2.1% and -5.8 ± 3.4%.
Repeated measures ANOVAwith Greenhouse-Geisser correc-
tion showed a significant difference between measurement
errors of different scan protocols (F = 9.62, P < 0.001)). Post
hoc tests revealed that measurement errors at the lowest dose
protocol (120 kVp 50 mAs) were significantly higher than at
140 kVp 200 mAs (P = 0.013), 140 kVp 100 mAs (P = 0.016)
and 140 kVp 50 mAs (P = 0.025), respectively. No significant
differences were found between the other protocols. For all
scan protocols, no significant differences were found between
BMD measurements at different IR levels; repeated measures
ANOVAwith Greenhouse-Geisser correction were P > 0.05.
At both 120 and 140 kVp, strong linear correlations (R2 =
0.973 and 0.970, respectively, P < 0.001) were found between
BMD measurements on SDCT and aBMD measurements on
DXA (Fig. 4). A positive intercept on the DXA-axis of 0.21 g/
cm2 was found at both 120 and 140 kVp. The coefficients
[95% CI] yielded β = 0.007 [0.007–0.008] at 120 kVp and
β = 0.007 [0.006–0.007] at 140 kVp.
Discussion
In this systematic phantom study, we showed that BMD can
be quantified with an overall high accuracy on various dual-
layer spectral detector CT protocols. In addition, a strong
linear correlation was demonstrated between BMD measure-
ments on SDCT and DXA. This indicates that SDCT could
potentially open up the possibilities of BMD quantification on
routinely acquired SDCT scans for any indication without
exposing patients to additional ionizing radiation.
The American College of Radiology defined a BMD of
<80 mg/cm3 as osteoporosis and 80–120 mg/cm3 as
osteopenic [29]. In the (patho)physiological range of 50–
200 mg/cm3 HA, we found an overall mean measurement
error of 6% or less. This range of HA is a representative
coverage of the amount of trabecular BMD clinically encoun-
tered at all age groups [24], and therefore important for testing
our quantitative method before using it in clinical practice. In
addition, scans were made using various settings to simulate
clinically used abdominal, chest and spine SDCT imaging
protocols. Overall small differences (≤5%) were observed be-
tween scan protocols, implying the possibility for follow-up of
BMD, measured on SDCT scans made for different indica-
tions. An exception to this small difference of ≤5% is the
120 kVp 50 mAs protocol, the largest measurement error (-
5.8 ± 3.4%) and largest mean difference between protocols
(10%) was found for measurements made at this lowest dose
protocol (Fig. 3). Measurements at this lowest dose protocol
were significantly lower than all 140 kVp acquisitions proto-
cols. Because no significant differences were found between
BMD measurements at different iterative reconstruction
levels, it is likely that results were only slightly influenced
by noise. Increased measurement errors at this lowest dose
protocol can be potentially explained by spectral separation.
When scanning with a lower tube voltage, less high-energy
photons are emitted and therefore the spectral overlap between
the high- and low-energy spectra increases and spectral sepa-
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Fig. 4 Comparison of BMD
measurements on SDCT and
aBMD measurements on DXA.
Scatter plots with linear fit show a
strong correlation. aBMD areal
bone mineral density, BMD bone
mineral density, DXA dual energy
X-ray absorptiometry, kVp
kilovoltage peak, SDCT dual-
layer spectral detector computed
tomography
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decreases the number of photons emitted, thereby decreasing
the number of photons that hit the detector. Both factors could
influence the accuracy of the mass attenuation coefficient
across monochromatic energies and thereby the accuracy of
BMD quantification.
The influence of this decreased number of photons that hit
the detector can be seen when comparing scan protocols,
where an increase in mean measurement error is seen when
lowering tube current (Table 2, Fig. 3). An exception is found
for the 120 kVp 100 mAs protocol at 100 mg/cm3 and the 140
kVp 50 mAs protocol at 200 mg/cm3. However, a larger SD
was also found for these protocols. Indicating that, despite a
slightly less underestimated mean measurement error, accura-
cy was not evidently better. It remains unclear which factors
caused these increased mean measurement errors. As de-
scribed before, no significant differences were found when
applying iterative reconstruction levels, indicating that it is
likely that noise was of little influence. Interscan and
intraobserver variation could be an influence, therefore these
factors should be evaluated in future research.
Since the commercial introduction of DECT a decade ago,
several studies have described the feasibility of BMD quanti-
fication [20–23, 30]. Wesarg and colleagues described that a
3D display of BMD distribution obtained with a dual source
DECT gave more detailed information of focal bone solidity
compared to BMD measured on DXA [20, 21]. However,
measurement errors were not assessed. Wait et al. [23] de-
scribed a root-mean-square error accuracy of at best of 9%
when assessing BMD, expressed as K2HPO4 ranging from 0
to 600mg/ml, in a phantom scanned with rapid kVp switching
DECT. In accordance with our study, mass attenuation coeffi-
cients were obtained from the National Institute of Standards
and Technology database to determine material density. In this
way, no calibration phantom is needed, making (retrospective)
BMD measurements on scans made for another indication
than BMD possible. In a recent study Hofmann and col-
leagues presented a three-material decomposition method for
BMD quantification on DECT, which they tested on the ESP
[22]. They found a mean measurement error of about 3.5%
over all HA concentrations and beam voltages, which is in
accordance with the mean measurement error of -2.2 ± 3.3%
we found over all HA concentrations and beam voltages in the
present study. In addition, Hofmann et al. found an overesti-
mation in HU scores obtained by quantitative CTwhen com-
pared to their method and guidelines of the American College
of Radiology, which underscores that DECT has better accu-
racy compared to quantitative CT [22].
In our study we observed a linear correlation between
BMDmeasurements performed on SDCTand DXA. In accor-
dance with Wait et al. [23], the linear correlation had a higher
intercept at the DXA-axis (Fig. 4). A possible explanation for
this higher intercept, and thus overestimation of DXA com-
pared to SDCT, can be found in the fact that DXA also takes
into account cortical bone, whereas our proposed SDCTmeth-
od only takes into account trabecular bone. Surrounding struc-
tures and spinal changes that influence the DXA are ignored
by the proposed SDCT method; while not evaluated in the
current phantom setup, this may be of influence in a patient
study. This effect of surrounding structures has been empha-
sized, leading to a decrease of correlation, by prior phantom,
cadaver and patient studies [20, 21, 23].
In the present study we propose a relatively easy material
decomposition method for BMD quantification using mass
attenuation coefficient across monochromatic energies obtain-
ed from SDCT. The monochromatic image formation was
performed on the raw data in the projection space, thereby
effectively eliminating beam hardening artefacts [31]. Dual
energy CT, using high monochromatic images (>95 keV),
has been shown to successfully reduce metal artefacts in pa-
tients, while at low monochromatic energies metal artefacts
were more enhanced [26, 27]. For our method we obtained
monochromatic images at energy levels between 90 and
200 keV, suffering the least from metal artefacts. Together
with the elimination of beam hardening and slice selective
measurements, our proposed method may allow for BMD
assessment of tissue surrounded by metal implants and there-
by evaluate degeneration and assess the risk for
(postoperative) fractures; however, further research on this
topic is needed.
Our study has some limitations. We used a phantom setup
and have not yet validated our method on patients. However,
by using a phantom we were able to systematically test our
quantification method in an optimally controlled setting with a
clinically relevant range of known BMD concentrations. In
addition, we were able to evaluate multiple scans protocols
on an unmoved phantom, thereby minimizing interscan vari-
ation, which in a patient setting would add up to a high dose.
Nonetheless, our method has to be verified in a patient study
in future research. A second limitation is that we used a phan-
tom without contrast medium, therefore the influence of con-
trast medium was not evaluated. Future research will have to
address a three or multi-material decomposition, taking into
account the attenuation coefficient of contrast medium. A
third limitation is that we used a phantom that resembles the
lumbar region, this could potentially introduce errors for the
SDCT imaging protocols that simulate chest protocols. A
fourth limitation is that we used a relatively small phantom,
as the ESP represents a small adult person. One would expect
more noise when larger phantoms (or patients) are imaged,
which could potentially influence the accuracy in a negative
way, especially for the lower dose protocols. However, one
could argue that the noise encountered at 50 mAs in our phan-
tom would be the same amount of noise encountered at a 100-
or 200-mAs protocol in a larger patient. A fifth limitation is
that we only evaluated the SDCT, therefore our results may be
limited to the DECT technique described in this study.
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In conclusion, we demonstrated that BMD can be accurate-
ly quantified with a novel dual-layer SDCT system using var-
ious acquisition protocols. Care should be taken when lower-
ing the dose, as we found increased measurement errors and
significant differences between other protocols for measure-
ments made at the lowest dose protocol. A strong linear cor-
relation between all SDCT measurements and DXA measure-
ments was obtained. Our results potentially opens up the pos-
sibilities for osteoporosis evaluation and opportunistic screen-
ing on SDCT scans made for other clinical indications.
However, patient studies are needed to extend and translate
our findings.
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